SDC4 and metabolic dysfunction-associated steatotic liver disease: Existing studies highlighted the significant role of SDC4 as a potential marker for myocardial infarction [15], nonalcoholic fatty liver disease [16], and endothelial dysfunction in patients with resistant hypertension [17].